Shares of Tenon Medical, Inc. (NASDAQ:TNON – Free Report) are scheduled to reverse split on the morning of Monday, August 10th. The 1-35 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, August 9th.
Tenon Medical Price Performance
Shares of TNON traded down $0.02 during mid-day trading on Thursday, hitting $0.17. 1,838,470 shares of the company’s stock were exchanged, compared to its average volume of 1,049,591. Tenon Medical has a fifty-two week low of $0.16 and a fifty-two week high of $1.74. The business’s 50 day moving average is $0.38 and its two-hundred day moving average is $0.65.
Tenon Medical (NASDAQ:TNON – Get Free Report) last released its quarterly earnings results on Tuesday, May 12th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.01). The company had revenue of $1.38 million for the quarter, compared to analysts’ expectations of $1.30 million. Tenon Medical had a negative return on equity of 907.60% and a negative net margin of 270.09%.
Analysts Set New Price Targets
Institutional Investors Weigh In On Tenon Medical
Hedge funds have recently added to or reduced their stakes in the company. Jane Street Group LLC purchased a new stake in Tenon Medical in the 1st quarter valued at approximately $29,000. Geode Capital Management LLC increased its stake in Tenon Medical by 34.6% during the fourth quarter. Geode Capital Management LLC now owns 66,640 shares of the company’s stock worth $63,000 after acquiring an additional 17,137 shares during the last quarter. Finally, DRW Securities LLC purchased a new position in shares of Tenon Medical in the 4th quarter worth about $98,000. Institutional investors and hedge funds own 22.74% of the company’s stock.
About Tenon Medical
Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.
Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.
Further Reading
- Five stocks we like better than Tenon Medical
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
